Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4966

Next 25
Website Changes
03/21/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
03/20/2017 Is it time for "Conditional Approvals"?
03/17/2017 Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
03/17/2017 Antibody treats pediatric brain tumors safely and effectively in mice
03/17/2017 Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines™
03/10/2017 Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
03/10/2017 4th ANNUAL HOOPS FOR HANNAH FUNDRAISER FOR BRAIN TUMOR RESEARCH
03/10/2017 Ependymoma Awareness Day.
03/10/2017 Clinical Trial Announcement Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Glioblastoma at First Recurrence or Progression
03/10/2017 Trump Chooses Dr. Scott Gottlieb To Head Food And Drug Administration
03/09/2017 Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization
03/08/2017 Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.
03/08/2017 Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children set to open soon
03/07/2017 Help us better Understand Patient Experiences with Glioblastoma Multiforme
02/26/2017 Renowned Neuro-oncologist Joining Northwestern
02/23/2017 Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma
02/22/2017 UPDATED: Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII
02/21/2017 Help us better Understand Patient Experiences with Glioblastoma Multiforme
02/09/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
02/09/2017 TRACON Pharmaceuticals Announces Top-line Results from NCI-Sponsored Phase 2 Trial of TRC105 in Recurrent Glioblastoma
02/09/2017 Trials Open for Enrollment: Phase II Study of VAL-083 in Patients with MGMT-unmethylated Bevacizumab-naïve Recurrent Glioblastoma Multiforme
02/07/2017 DelMar Pharmaceuticals Inc (DMPI) Moves Forward With Flagship Chemotherapy Into Phase II
02/06/2017 NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA
02/04/2017 17th Annual UCLA Brain Tumor Conference
02/04/2017 Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites